Request mobile services easily, or book your appointment at our comfortable facilities
The Legal Arguments Plaintiffs Claim: Manufacturers (Novo Nordisk, Eli Lilly) knew or should have known about risks of gastroparesis and NAION Warning labels failed to adequately disclose these serious side effects Drugs were aggressively marketed as safe and effective weight loss solutions without proper risk disclosure Patients would not have taken the medications had they known the true risks Defendants Respond: Claims are unfounded (Novo Nordisk statement) Will defend vigorously against lawsuits Motion to dismiss expected January 24, 2025 Argue that labels were adequate and that many conditions may be pre-existing or related to diabetes itself Whos Most at Risk
This may be related to genetic background, disease progression, islet function, obesity, lifestyle and other factors
Health economic benefits are essential if the manufacturers are going to make oral obesity drugs popular on the market
We dive into why alcohol, stress, and aging deplete glutathione, why most supplements and IV drips dont work, and how to know if your body is lacking this essential antioxidant even before symptoms appear
What Is EstroGel
